Glioblastoma multiforme
RecruitingLong-term safety study of Temferon (modified stem cells with interferon-α2) in patients previously treated for glioblastoma multiforme
Long-term safety study of Temferon (modified stem cells with interferon-α2) in patients previously treated for glioblastoma multiforme
- Disease:Glioblastoma multiforme
- Substances:Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Transduced With A Lentiviral Vector Encoding The Interferon Alpha-2 Gene
Italy- Participants:18–64 years · 65+ years
- Substances:Autologous Cd34+ Haematopoietic Stem And Progenitor Cells Transduced With A Lentiviral Vector Encoding The Interferon Alpha-2 Gene
- Sponsor:Genenta Science S.p.A.

